Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Fennec Pharmaceuticals (FENC) FCF Margin (2020 - 2025)

Fennec Pharmaceuticals' FCF Margin history spans 6 years, with the latest figure at 43.28% for Q4 2025.

  • For the quarter ending Q4 2025, FCF Margin fell 2468.0% year-over-year to 43.28%, compared with a TTM value of 27.94% through Dec 2025, down 8103.0%, and an annual FY2025 reading of 27.94%, down 8469.0% over the prior year.
  • FCF Margin for Q4 2025 was 43.28% at Fennec Pharmaceuticals, down from 11.98% in the prior quarter.
  • The five-year high for FCF Margin was 49177.78% in Q2 2021, with the low at 332.56% in Q1 2023.
  • Average FCF Margin over 5 years is 3852.39%, with a median of 31.63% recorded in 2024.
  • Year-over-year, FCF Margin crashed -4323041bps in 2022 and then soared 47957bps in 2024.
  • Tracing FENC's FCF Margin over 5 years: stood at 5378.18% in 2021, then crashed by -86bps to 744.2% in 2022, then tumbled by -107bps to 49.92% in 2023, then surged by 63bps to 18.6% in 2024, then tumbled by -133bps to 43.28% in 2025.
  • Per Business Quant, the three most recent readings for FENC's FCF Margin are 43.28% (Q4 2025), 11.98% (Q3 2025), and 38.19% (Q2 2025).